Use of Nanocarriers Containing Antitrypanosomal Drugs for the Treatment of Chagas Disease

Chagas disease, caused by the <i>Trypanosoma cruzi</i> parasitic protozoan, is a neglected tropical disease (NTD) of significant incidence in Latin America. Transmission to humans and other mammals is mainly via the vector insect from the Reduviidae family, popularly known as the kissing...

Full description

Bibliographic Details
Published in:Pharmaceuticals
Main Authors: Diogo de Freitas Paiva, Ana Paula dos Santos Matos, Denise de Abreu Garófalo, Tatielle do Nascimento, Mariana Sato de Souza de Bustamante Monteiro, Ralph Santos-Oliveira, Eduardo Ricci-Junior
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Subjects:
nanocarriers
Chagas disease
<i>Trypanosoma cruzi</i>
in vivo assays
Online Access:https://www.mdpi.com/1424-8247/16/8/1163

Internet

https://www.mdpi.com/1424-8247/16/8/1163

Similar Items